首页 › 基金 › William Allan Corp › WST
William Allan Corp 对 WST 的持仓历史
WEST PHARMACEUTICAL SVSC INC · 医疗保健
William Allan Corp 在 Q3 2026 的 13F 申报中披露持有 WST(WEST PHARMACEUTICAL SVSC INC)13,228 股,市值约 US$4.9M,约占其申报组合的 2.46%,在其申报持仓中市值排名第 15 位。 William Allan Corp 最近 10 个申报季度中有 10 个季度披露了 WST 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-10-14 · 来源: SEC EDGAR Form 13F-HR
William Allan Corp 对 WST 的持仓演变
William Allan Corp 于 Q2 2024 首次披露 WST 持仓:3,295 股(约 US$1.1M)。 该持仓在 Q3 2026 达到峰值 13,228 股,市值约 US$4.9M。 在 10 次申报中,William Allan Corp 5 次增持、4 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 13,228 股、市值约 US$4.9M,环比减持 -121 股。。 持仓曾出现大幅变动:Q3 2024 增持约 112% (随后一个季度股价上涨 9%)、Q1 2025 增持约 45% (随后一个季度股价下跌 2%)、Q2 2025 增持约 33% (随后一个季度股价上涨 20%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 3.29K | $1.08M | 新进 |
| Q3 2024 | 7.00K | $1.11M | 增持 |
| Q4 2024 | 7.38K | $2.42M | 增持 |
| Q1 2025 | 10.72K | $2.40M | 增持 |
| Q2 2025 | 14.28K | $3.12M | 增持 |
| Q3 2025 | 13.82K | $3.63M | 减持 |
| Q4 2025 | 13.16K | $3.62M | 减持 |
| Q1 2026 | 13.53K | $3.39M | 增持 |
| Q2 2026 | 13.35K | $4.79M | 减持 |
| Q3 2026 | 13.23K | $4.90M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 WST 与 13F 数据
WST(WEST PHARMACEUTICAL SVSC INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 WST,申报仓位最大的包括:Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 WST 的基金
- Artisan Partners Limited Partnership 2.41M 股 · $865.83M · Q2 2026
- GENERATION INVESTMENT MANAGEMENT LLP 2.03M 股 · $728.17M · Q2 2026
- BROWN ADVISORY INC 1.08M 股 · $386.04M · Q2 2026
- Longview Partners (Guernsey) LTD 1.03M 股 · $371.14M · Q2 2026
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 760.62K 股 · $273.06M · Q2 2026
- ProShare Advisors LLC 598.02K 股 · $214.69M · Q2 2026
- Findlay Park Partners LLP 596.65K 股 · $214.20M · Q2 2026
- Epoch Investment Partners, Inc. 562.56K 股 · $201.96M · Q2 2026
- JACOBS LEVY EQUITY MANAGEMENT, INC 507.79K 股 · $182.30M · Q2 2026
更多关于 William Allan Corp
常见问题
How long has William Allan Corp held WST?
William Allan Corp has disclosed WST holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is William Allan Corp's current position in WST?
As of Q3 2026, William Allan Corp holds 13.23K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $4.90M, representing 2.46% of its reported portfolio and ranking #15.
Has William Allan Corp been buying or selling WST?
In the latest 13F filing (Q3 2026), William Allan Corp reduced its position in WST. The position peaked in Q3 2026 at 13.23K shares.
Which other funds hold WST?
Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.